Arkolith/Insider Trading/DCPH/Form 4

Pitman Jama

SVP, Chief Development OfficerDeciphera Pharmaceuticals, Inc. (DCPH) · full profile →Form 4 · filed Feb 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$35K
Net Open-Market Flow
-$35K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 16, 2024Sell(S)2K$15.62$35K68K
Feb 15, 2024Grant(A)10K—$060K
Feb 15, 2024Grant(A)10K—$070K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2024Grant(A)39K—$039K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-017084) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML